Exact Mass: 478.32220600000005
Exact Mass Matches: 478.32220600000005
Found 500 metabolites which its exact mass value is equals to given mass value 478.32220600000005
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Dehydroemetine
P - Antiparasitic products, insecticides and repellents > P01 - Antiprotozoals > P01A - Agents against amoebiasis and other protozoal diseases C254 - Anti-Infective Agent > C276 - Antiparasitic Agent > C277 - Antiprotozoal Agent
Polyporusterone A
Polyporusterone A is found in mushrooms. Polyporusterone A is a constituent of Polyporus umbellatus (zhu ling). Constituent of Polyporus umbellatus (zhu ling). Polyporusterone A is found in mushrooms. Polyporusterone A is a triterpene carboxylic acid isolated from Polyporus umbellatus Fries. Polyporusterone A has inhibitory effect on free radical-induced lysis of red blood cells (hemolysis)[1]. Polyporusterone A is a triterpene carboxylic acid isolated from Polyporus umbellatus Fries. Polyporusterone A has inhibitory effect on free radical-induced lysis of red blood cells (hemolysis)[1].
Dolicholide
Dolicholide is found in common bean. Dolicholide is a constituent of Dolichos lablab (hyacinth bean).
25-Acetylvulgaroside
25-Acetylvulgaroside is found in fruits. 25-Acetylvulgaroside is a constituent of Cydonia vulgaris (quince). Constituent of Cydonia vulgaris (quince). 25-Acetylvulgaroside is found in fruits.
Erinacine D
Erinacine D is found in mushrooms. Erinacine D is a metabolite of Hericium erinaceum (lions mane Metabolite of Hericium erinaceum (lions mane). Erinacine D is found in mushrooms.
(1‐{[1‐carboxylato‐3‐(trimethylammonio)propan‐2‐ yl]oxy}‐1‐oxoicosa‐5,7,11,14‐tetraen‐9‐yl)peroxy
C27H44NO6 (478.31684640000003)
(1‐{[1‐Carboxylato‐3‐(trimethylammonio)propan‐2‐ yl]oxy}‐1‐oxoicosa‐5,7,11,14‐tetraen‐9‐yl)peroxy is an acylcarnitine. More specifically, it is an (1‐carboxynonadeca‐4,6,10,13‐tetraen‐8‐yl)peroxy ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279 ). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. (1‐{[1‐Carboxylato‐3‐(trimethylammonio)propan‐2‐ yl]oxy}‐1‐oxoicosa‐5,7,11,14‐tetraen‐9‐yl)peroxy is therefore classified as a long chain AC. As a long-chain acylcarnitine (1‐{[1‐carboxylato‐3‐(trimethylammonio)propan‐2‐ yl]oxy}‐1‐oxoicosa‐5,7,11,14‐tetraen‐9‐yl)peroxy is generally formed through esterification with long-chain fatty acids obtained from the diet. The main function of most long-chain acylcarnitines is to ensure long chain fatty acid transport into the mitochondria (PMID: 22804748 ). Altered levels of long-chain acylcarnitines can serve as useful markers for inherited disorders of long-chain fatty acid metabolism. Carnitine palmitoyltransferase I (CPT I, EC:2.3.1.21) is involved in the synthesis of long-chain acylcarnitines (more than C12) on the mitochondrial outer membrane. Elevated serum/plasma levels of long-chain acylcarnitines are not only markers for incomplete FA oxidation but also are indicators of altered carbohydrate and lipid metabolism. High serum concentrations of long-chain acylcarnitines in the postprandial or fed state are markers of insulin resistance and arise from insulins inability to inhibit CPT-1-dependent fatty acid metabolism in muscles and the heart (PMID: 19073774 ). Increased intracellular content of long-chain acylcarnitines is thought to serve as a feedback inhibition mechanism of insulin action (PMID: 23258903 ). In healthy subjects, increased concentrations of insulin effectively inhibits long-chain acylcarnitine production. Several studies have also found increased levels of circulating long-chain acylcarnitines in chronic heart failure patients (PMID: 26796394 ). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].
(20‐{[1‐Carboxylato‐3‐(trimethylammonio)propan‐2‐ yl]oxy}‐20‐oxoicosa‐6,8,12,15‐tetraen‐10‐yl)peroxy
C27H44NO6 (478.31684640000003)
(20‐{[1‐Carboxylato‐3‐(trimethylammonio)propan‐2‐ yl]oxy}‐20‐oxoicosa‐6,8,12,15‐tetraen‐10‐yl)peroxy is an acylcarnitine. More specifically, it is an [(4Z,7Z,11E,13Z)-1-carboxynonadeca-4,7,11,13-tetraen-10-yl]peroxy ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. (20‐{[1‐Carboxylato‐3‐(trimethylammonio)propan‐2‐ yl]oxy}‐20‐oxoicosa‐6,8,12,15‐tetraen‐10‐yl)peroxy is therefore classified as a long chain AC. As a long-chain acylcarnitine (20‐{[1‐carboxylato‐3‐(trimethylammonio)propan‐2‐ yl]oxy}‐20‐oxoicosa‐6,8,12,15‐tetraen‐10‐yl)peroxy is generally formed through esterification with long-chain fatty acids obtained from the diet. The main function of most long-chain acylcarnitines is to ensure long chain fatty acid transport into the mitochondria (PMID: 22804748). Altered levels of long-chain acylcarnitines can serve as useful markers for inherited disorders of long-chain fatty acid metabolism. Carnitine palmitoyltransferase I (CPT I, EC:2.3.1.21) is involved in the synthesis of long-chain acylcarnitines (more than C12) on the mitochondrial outer membrane. Elevated serum/plasma levels of long-chain acylcarnitines are not only markers for incomplete FA oxidation but also are indicators of altered carbohydrate and lipid metabolism. High serum concentrations of long-chain acylcarnitines in the postprandial or fed state are markers of insulin resistance and arise from insulins inability to inhibit CPT-1-dependent fatty acid metabolism in muscles and the heart (PMID: 19073774). Increased intracellular content of long-chain acylcarnitines is thought to serve as a feedback inhibition mechanism of insulin action (PMID: 23258903). In healthy subjects, increased concentrations of insulin effectively inhibits long-chain acylcarnitine production. Several studies have also found increased levels of circulating long-chain acylcarnitines in chronic heart failure patients (PMID: 26796394). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].
Valyl-leucyl-lysine 4-nitroanilide
Homocastasterone
H-D-Val-Leu-Lys-pNA
(24S)-24-Ethylbrassinone
(24s)-24-ethylbrassinone is practically insoluble (in water) and a very weakly acidic compound (based on its pKa). (24s)-24-ethylbrassinone can be found in tea, which makes (24s)-24-ethylbrassinone a potential biomarker for the consumption of this food product.
24-Ethylbrassinone
24-ethylbrassinone is practically insoluble (in water) and a very weakly acidic compound (based on its pKa). 24-ethylbrassinone can be found in tea, which makes 24-ethylbrassinone a potential biomarker for the consumption of this food product.
6-Keto-28-homobrassinolide
6-keto-28-homobrassinolide belongs to stigmastanes and derivatives class of compounds. Those are sterol lipids with a structure based on the stigmastane skeleton, which consists of a cholestane moiety bearing an ethyl group at the carbon atom C24. 6-keto-28-homobrassinolide is practically insoluble (in water) and a very weakly acidic compound (based on its pKa). 6-keto-28-homobrassinolide can be found in tea, which makes 6-keto-28-homobrassinolide a potential biomarker for the consumption of this food product.
Ikarugamycin
A polyketide macrolactam containing a tetramic acid (pyrrolidine-2,4-dione) ring system. It is isolated from Streptomyces as an antibiotic with antiprotozoal and cytotoxic activities. D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams
(2beta,3beta,14alpha,20R,22R)-2,3,14,20,22,25-hexahydroxycholesta-4,7-dien-6-one
1beta,2beta,3beta,4beta,5beta-pentahydroxyspirost-25(27)-ene|Delta25(27)-pentrogenin|Delta25(27)pentologenin|Delta25(27)pentrogenin|spirost-25(27)-ene-1beta,2beta,3beta,4beta,5beta-pentaol
(13R)-labda-7,14-diene 13-O-alpha-L-(4-O-acetyl)-6-deoxyidopyranoside|labda-7,14-dien-13(R)-ol-4-O-acetyl-alpha-L-6-deoxyidopyranoside
astern-13(S)-1(10),14-diene-13-O-alpha-L-2-acetylrhamnopyranoside
14alpha,15alpha-epoxy-14,15-dihydrostachysterone B
abiesanolide B|methyl 3,4-seco-8(14->13R)abeo-17,13-friedo-9beta-lanosta-4(28),7,14(30),22Z,24-pentaen-26,23-olide-3-oate
labda-7,14-dien-13(R)-ol-2-O-acetyl-alpha-L-rhamnopyranoside
amphimedoside C|N-methoxy-N-(14-pyridin-3-yltetradec-11-yn-1-yl)-beta-D-glucopyranosylamine
7beta-acetoxy-6alpha-(2-methylbutyryloxy)-13,14-dihydrokolavenic acid methyl ester|7beta-acetoxy-6alpha-<2-methylbutyryloxy>-13,14-dihydrokolavenic acid methyl ester
(25S)-3beta,4beta,6alpha,8,26-pentahydroxy-24-methyl-5alpha-cholest-24(241)-en-15-one|certonardosterol Q1
labda-7,14-dien-13(R)-ol-3-O-acetyl-alpha-L-rhamnopyranoside
9,10-epoxy-6alpha-O-tigloyl-7alphaH-8beta-O-(3-acetoxy-2-methylbutyryl)germacra-3(4)E-ene|trijugin I
ST 28:2;O6
Polyporusterone A is a steroid. Polyporusterone A is a natural product found in Polyporus umbellatus with data available. Polyporusterone A is a triterpene carboxylic acid isolated from Polyporus umbellatus Fries. Polyporusterone A has inhibitory effect on free radical-induced lysis of red blood cells (hemolysis)[1]. Polyporusterone A is a triterpene carboxylic acid isolated from Polyporus umbellatus Fries. Polyporusterone A has inhibitory effect on free radical-induced lysis of red blood cells (hemolysis)[1].
2-[(6,7-dimethoxy-3,4-dihydroisoquinolin-1-yl)methyl]-3-ethyl-9,10-dimethoxy-2,3,4,6,7,11b-hexahydro-1H-benzo[a]quinolizine
(2S,3R,10R,13R,14S)-17-[(2R,3R,5S)-2,3-dihydroxy-5,6-dimethylheptan-2-yl]-2,3,14-trihydroxy-10,13-dimethyl-2,3,4,5,9,11,12,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-6-one
2-[(6,7-dimethoxy-3,4-dihydroisoquinolin-1-yl)methyl]-3-ethyl-9,10-dimethoxy-2,3,4,6,7,11b-hexahydro-1H-benzo[a]quinolizine
(2S,3R,10R,13R,14S)-17-[(2R,3R,5S)-2,3-dihydroxy-5,6-dimethylheptan-2-yl]-2,3,14-trihydroxy-10,13-dimethyl-2,3,4,5,9,11,12,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-6-one [IIN-based on: CCMSLIB00000848325]
(2S,3R,10R,13R,14S)-17-[(2R,3R,5S)-2,3-dihydroxy-5,6-dimethylheptan-2-yl]-2,3,14-trihydroxy-10,13-dimethyl-2,3,4,5,9,11,12,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-6-one [IIN-based: Match]
Ala Ile Ile Tyr
Ala Ile Leu Tyr
Ala Ile Tyr Ile
Ala Ile Tyr Leu
Ala Leu Ile Tyr
Ala Leu Leu Tyr
Ala Leu Tyr Ile
Ala Leu Tyr Leu
Ala Tyr Ile Ile
Ala Tyr Ile Leu
Ala Tyr Leu Ile
Ala Tyr Leu Leu
Phe Gly Lys Lys
Phe Ile Ile Ser
Phe Ile Leu Ser
Phe Ile Ser Ile
Phe Ile Ser Leu
Phe Ile Thr Val
Phe Ile Val Thr
Phe Lys Gly Lys
Phe Lys Lys Gly
Phe Leu Ile Ser
Phe Leu Leu Ser
Phe Leu Ser Ile
Phe Leu Ser Leu
Phe Leu Thr Val
Phe Leu Val Thr
Phe Ser Ile Ile
Phe Ser Ile Leu
Phe Ser Leu Ile
Phe Ser Leu Leu
Phe Thr Ile Val
Phe Thr Leu Val
Phe Thr Val Ile
Phe Thr Val Leu
Phe Val Ile Thr
Phe Val Leu Thr
Phe Val Thr Ile
Phe Val Thr Leu
Gly Phe Lys Lys
Gly Lys Phe Lys
Gly Lys Lys Phe
His Ile Ile Pro
His Ile Leu Pro
His Ile Pro Ile
His Ile Pro Leu
His Leu Ile Pro
His Leu Leu Pro
His Leu Pro Ile
His Leu Pro Leu
His Pro Ile Ile
His Pro Ile Leu
His Pro Leu Ile
His Pro Leu Leu
Ile Ala Ile Tyr
Ile Ala Leu Tyr
Ile Ala Tyr Ile
Ile Ala Tyr Leu
Ile Phe Ile Ser
Ile Phe Leu Ser
Ile Phe Ser Ile
Ile Phe Ser Leu
Ile Phe Thr Val
Ile Phe Val Thr
Ile His Ile Pro
Ile His Leu Pro
Ile His Pro Ile
Ile His Pro Leu
Ile Ile Ala Tyr
Ile Ile Phe Ser
Ile Ile His Pro
Ile Ile Pro His
Ile Ile Ser Phe
Ile Ile Tyr Ala
Ile Leu Ala Tyr
Ile Leu Phe Ser
Ile Leu His Pro
Ile Leu Pro His
Ile Leu Ser Phe
Ile Leu Tyr Ala
Ile Pro His Ile
Ile Pro His Leu
Ile Pro Ile His
Ile Pro Leu His
Ile Ser Phe Ile
Ile Ser Phe Leu
Ile Ser Ile Phe
Ile Ser Leu Phe
Ile Thr Phe Val
Ile Thr Val Phe
Ile Val Phe Thr
Ile Val Thr Phe
Ile Tyr Ala Ile
Ile Tyr Ala Leu
Ile Tyr Ile Ala
Ile Tyr Leu Ala
Lys Phe Gly Lys
Lys Phe Lys Gly
Lys Gly Phe Lys
Lys Gly Lys Phe
Lys Lys Phe Gly
Lys Lys Gly Phe
Leu Ala Ile Tyr
Leu Ala Leu Tyr
Leu Ala Tyr Ile
Leu Ala Tyr Leu
Leu Phe Ile Ser
Leu Phe Leu Ser
Leu Phe Ser Ile
Leu Phe Ser Leu
Leu Phe Thr Val
Leu Phe Val Thr
Leu His Ile Pro
Leu His Leu Pro
Leu His Pro Ile
Leu His Pro Leu
Leu Ile Ala Tyr
Leu Ile Phe Ser
Leu Ile His Pro
Leu Ile Pro His
Leu Ile Ser Phe
Leu Ile Tyr Ala
Leu Leu Ala Tyr
Leu Leu Phe Ser
Leu Leu His Pro
Leu Leu Pro His
Leu Leu Ser Phe
Leu Leu Tyr Ala
Leu Pro His Ile
Leu Pro His Leu
Leu Pro Ile His
Leu Pro Leu His
Leu Ser Phe Ile
Leu Ser Phe Leu
Leu Ser Ile Phe
Leu Ser Leu Phe
Leu Thr Phe Val
Leu Thr Val Phe
Leu Val Phe Thr
Leu Val Thr Phe
Leu Tyr Ala Ile
Leu Tyr Ala Leu
Leu Tyr Ile Ala
Leu Tyr Leu Ala
Pro His Ile Ile
Pro His Ile Leu
Pro His Leu Ile
Pro His Leu Leu
Pro Ile His Ile
Pro Ile His Leu
Pro Ile Ile His
Pro Ile Leu His
Pro Leu His Ile
Pro Leu His Leu
Pro Leu Ile His
Pro Leu Leu His
Ser Phe Ile Ile
Ser Phe Ile Leu
Ser Phe Leu Ile
Ser Phe Leu Leu
Ser Ile Phe Ile
Ser Ile Phe Leu
Ser Ile Ile Phe
Ser Ile Leu Phe
Ser Leu Phe Ile
Ser Leu Phe Leu
Ser Leu Ile Phe
Ser Leu Leu Phe
Thr Phe Ile Val
Thr Phe Leu Val
Thr Phe Val Ile
Thr Phe Val Leu
Thr Ile Phe Val
Thr Ile Val Phe
Thr Leu Phe Val
Thr Leu Val Phe
Thr Val Phe Ile
Thr Val Phe Leu
Thr Val Ile Phe
Thr Val Leu Phe
Val Phe Ile Thr
Val Phe Leu Thr
Val Phe Thr Ile
Val Phe Thr Leu
Val Ile Phe Thr
Val Ile Thr Phe
Val Leu Phe Thr
Val Leu Thr Phe
Val Thr Phe Ile
Val Thr Phe Leu
Val Thr Ile Phe
Val Thr Leu Phe
Val Val Val Tyr
Val Val Tyr Val
Val Tyr Val Val
Tyr Ala Ile Ile
Tyr Ala Ile Leu
Tyr Ala Leu Ile
Tyr Ala Leu Leu
Tyr Ile Ala Ile
Tyr Ile Ala Leu
Tyr Ile Ile Ala
Tyr Ile Leu Ala
Tyr Leu Ala Ile
Tyr Leu Ala Leu
Tyr Leu Ile Ala
Tyr Leu Leu Ala
Tyr Val Val Val
24-methylene-cholesterol sulfate
C28H46O4S (478.31166360000003)
Erinacine D
Dolicholide
Polyporusterone A
Polyporusterone A is a triterpene carboxylic acid isolated from Polyporus umbellatus Fries. Polyporusterone A has inhibitory effect on free radical-induced lysis of red blood cells (hemolysis)[1]. Polyporusterone A is a triterpene carboxylic acid isolated from Polyporus umbellatus Fries. Polyporusterone A has inhibitory effect on free radical-induced lysis of red blood cells (hemolysis)[1].
25-Acetylvulgaroside
N,N-dimethyl-4-[2-(2-octoxyphenyl)-6-phenylpyridin-4-yl]aniline
(9 9-BIS(2-ETHYLHEXYL)-9H-FLUORENE-2 7-&
C29H44B2O4 (478.34255240000005)
(5-Amino-2-butyl-3-benzofuranyl)[4-[3-(dibutylamino)propoxy]phenyl]methanone
C30H42N2O3 (478.31952620000004)
2-BROMO-17-(1,5-DIMETHYLHEXYL)-5,10,13-TRIMETHYLPERHYDROCYCLOPENTA[A]PHENANTHREN-3-ONE
Bis(2,6-di-Tert-Butyl-4-Methylphenoxy)Methylaluminum
C31H47AlO2 (478.33912719999995)
ETHYLTRI-N-OCTYLPHOSPHONIUM BROMIDE
C26H56BrP (478.33027660000005)
12-(Acetyloxy)-3,6-dihydroxy-7-oxocholan-24-oic acid methyl ester
sodium,(1S,2R,4aS,6aR,6aS,6bR,8aR,10S,12aR,14bS)-10-hydroxy-1,2,6a,6b,9,9,12a-heptamethyl-2,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-tetradecahydro-1H-picene-4a-carboxylate
N-(1-oxododecyl)-L-glutamic acid, compound with 2,2,2-nitrilotrisethanol (1:1)
C23H46N2O8 (478.32539959999997)
1,1,3,3-Tetraethoxy-1,3-dioctyldisiloxane
C24H54O5Si2 (478.35095939999997)
9,9-Dioctylfluorene-2,7-diboronic acid
C29H44B2O4 (478.34255240000005)
1,3-bis-(2,6-di-Isopropylphenyl)-4,5-dihydroimidazolium tetrafluoroborate
C27H39BF4N2 (478.31422519999995)
N-[2-[2-[(dipropylamino)methyl]piperidin-1-yl]ethyl]-6-oxo-5H-pyrido[2,3-b][1,4]benzodiazepine-11-carboxamide
C27H38N6O2 (478.30560879999996)
D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D010276 - Parasympatholytics
Valyl-leucyl-lysine 4-nitroanilide
D019995 - Laboratory Chemicals > D007202 - Indicators and Reagents > D002863 - Chromogenic Compounds D004396 - Coloring Agents
N-oleoyl-sn-glycero-3-phosphoethanolamine(1-)
C23H45NO7P- (478.29334900000003)
(E)-16-(3-(4-hydroxy-3,5-dimethoxyphenyl)acryloyloxy)hexadecanoic acid
(2R,6Z,9Z,12Z,15Z)-3-oxo-2-[(2Z,5Z,8Z,11Z)-tetradeca-2,5,8,11-tetraenyl]octadeca-6,9,12,15-tetraenoic acid
(1-{[1-Carboxylato-3-(trimethylammonio)propan-2-yl]oxy}-1-oxoicosa-5,7,11,14-tetraen-9-yl)peroxy
C27H44NO6 (478.31684640000003)
(20-{[1-Carboxylato-3-(trimethylammonio)propan-2-yl]oxy}-20-oxoicosa-6,8,12,15-tetraen-10-yl)peroxy
C27H44NO6 (478.31684640000003)
[3-carboxy-2-[(E)-7-[2-[(E)-3-hydroxyoct-1-enyl]-5-oxocyclopent-2-en-1-yl]hept-5-enoyl]oxypropyl]-trimethylazanium
C27H44NO6+ (478.31684640000003)
[3-carboxy-2-[(E)-7-[(2Z)-5-hydroxy-2-[(E)-oct-2-enylidene]-3-oxocyclopentyl]hept-5-enoyl]oxypropyl]-trimethylazanium
C27H44NO6+ (478.31684640000003)
[3-carboxy-2-[(E)-7-[2-[(E)-3-hydroxyoct-1-enyl]-5-oxocyclopenten-1-yl]hept-5-enoyl]oxypropyl]-trimethylazanium
C27H44NO6+ (478.31684640000003)
(5Z,8Z,11Z,14Z)-N-[2-(5-hydroxy-2-oxo-2,3-dihydro-1H-indol-3-yl)ethyl]icosa-5,8,11,14-tetraenamide
C30H42N2O3 (478.31952620000004)
(5R,6S,9R)-5-methoxy-14-[(2-methoxy-1-oxoethyl)amino]-3,6,9-trimethyl-2-oxo-N-propan-2-yl-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-triene-8-carboxamide
(5R,6R,9R)-5-methoxy-14-[(2-methoxy-1-oxoethyl)amino]-3,6,9-trimethyl-2-oxo-N-propan-2-yl-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-triene-8-carboxamide
(5R,6R,9S)-5-methoxy-14-[(2-methoxy-1-oxoethyl)amino]-3,6,9-trimethyl-2-oxo-N-propan-2-yl-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-triene-8-carboxamide
1-[(5S,6S,9S)-5-methoxy-8-(2-methoxy-1-oxoethyl)-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-3-propan-2-ylurea
1-[(5S,6S,9R)-5-methoxy-8-(2-methoxy-1-oxoethyl)-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-3-propan-2-ylurea
1-[(5S,6R,9S)-5-methoxy-8-(2-methoxy-1-oxoethyl)-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-3-propan-2-ylurea
(2beta,3beta,9epsilon,17epsilon,22R)-2,3,14,20,22-Pentahydroxyergost-7-en-6-one
(2R,3S)-8-[3-(dimethylamino)prop-1-ynyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[(3-methylphenyl)methyl]amino]methyl]-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one
(5S,6S,9R)-5-methoxy-14-[(2-methoxy-1-oxoethyl)amino]-3,6,9-trimethyl-2-oxo-N-propan-2-yl-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-triene-8-carboxamide
(5S,6R,9S)-5-methoxy-14-[(2-methoxy-1-oxoethyl)amino]-3,6,9-trimethyl-2-oxo-N-propan-2-yl-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-triene-8-carboxamide
(5S,6S,9S)-5-methoxy-14-[(2-methoxy-1-oxoethyl)amino]-3,6,9-trimethyl-2-oxo-N-propan-2-yl-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-triene-8-carboxamide
(5S,6R,9R)-5-methoxy-14-[(2-methoxy-1-oxoethyl)amino]-3,6,9-trimethyl-2-oxo-N-propan-2-yl-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-triene-8-carboxamide
1-[(5S,6R,9R)-5-methoxy-8-(2-methoxy-1-oxoethyl)-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-3-propan-2-ylurea
1-[(5R,6R,9R)-5-methoxy-8-(2-methoxy-1-oxoethyl)-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-3-propan-2-ylurea
1-[(5R,6R,9S)-5-methoxy-8-(2-methoxy-1-oxoethyl)-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-3-propan-2-ylurea
1-[(5R,6S,9R)-5-methoxy-8-(2-methoxy-1-oxoethyl)-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-3-propan-2-ylurea
(5Z)-7-{1-[(5S)-5-amino-5-carboxypentyl]-4-[(1E,3S)-3-hydroxyoct-1-en-1-yl]-2-methyl-5-oxo-2,5-dihydro-1H-pyrrol-3-yl}hept-5-enoic acid
2-[4-(2-Aminoethyl)-2-hydroxyphenoxy]ethyl-trimethylammonium 2-[5-(2-aminoethyl)-2-hydroxyphenoxy]ethyl-trimethylammonium
(2-hydroxy-3-phosphonooxypropyl) (Z)-henicos-11-enoate
[17-[(E)-5,6-dimethylhept-3-en-2-yl]-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] hydrogen sulfate
C28H46O4S (478.31166360000003)
[(E)-3-hydroxy-2-(nonanoylamino)non-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate
[(E)-2-(hexanoylamino)-3-hydroxydodec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate
[(E)-2-(heptanoylamino)-3-hydroxyundec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate
[(E)-3-hydroxy-2-(octanoylamino)dec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate
[(E)-2-(butanoylamino)-3-hydroxytetradec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate
[(E)-3-hydroxy-2-(propanoylamino)pentadec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate
[(E)-2-acetamido-3-hydroxyhexadec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate
[(E)-3-hydroxy-2-(pentanoylamino)tridec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate
[(E)-2-(decanoylamino)-3-hydroxyoct-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate
2-[[3-[(9Z,12Z)-hexadeca-9,12-dienoxy]-2-hydroxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
C24H49NO6P+ (478.32973240000007)
pregnenolone 3-beta-D-glucoside
A sterol 3-beta-D-glucoside in which the sterol is 3beta-hydroxypregn-5-en-20-one.
N-arachidonoyl-2-oxoserotonin
C30H42N2O3 (478.31952620000004)
A fatty amide obtained by formal condensation of the carboxy group of arachidonic acid with the amino group of 2-oxoserotonin.
TG(25:3)
Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved
LSM(19:1)
C24H51N2O5P (478.35354060000003)
Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved
(2e,4e,6e,8e)-10-[(3z,3as,9ar,9bs)-3a,6,6,9a-tetramethyl-2,7-dioxo-hexahydro-1h-cyclopenta[a]naphthalen-3-ylidene]-2,4,6-trimethylundeca-2,4,6,8-tetraenoic acid
11-ethyl-2,20,27-trihydroxy-10-methyl-21,26-diazapentacyclo[23.2.1.0⁵,¹⁶.0⁷,¹⁵.0⁸,¹²]octacosa-1,3,13,17,20,26-hexaen-28-one
(1's,2r,2's,4's,7's,8'r,9's,12's,13's,14's,15's,16's,17's,18'r)-7',9',13'-trimethyl-5-methylidene-5'-oxaspiro[oxane-2,6'-pentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icosane]-14',15',16',17',18'-pentol
(1s,2s,3r,4s,7s,8r,11s,12r,14r,17s)-4,14-dihydroxy-4,8,11-trimethyl-15-methylidene-10,18-dioxatetracyclo[9.7.0.0²,⁷.0³,¹⁷]octadecan-12-yl octanoate
1-(5,6-dimethylhept-3-en-2-yl)-3a,3b,5,5a,7-pentahydroxy-9a,11a-dimethyl-decahydro-1h-cyclopenta[a]phenanthren-4-one
7',9',13'-trimethyl-5-methylidene-5'-oxaspiro[oxane-2,6'-pentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icosane]-14',15',16',17',18'-pentol
3,4,5-trihydroxy-6-{2-hydroxy-3-[(13-methyltetradecyl)oxy]propoxy}oxane-2-carboxylic acid
8a-[(acetyloxy)methyl]-3,6-dihydroxy-8-(3-hydroxy-3-methylpent-4-en-1-yl)-4,4-dimethyl-7-methylidene-hexahydro-1h-naphthalen-2-yl 2-methylbut-2-enoate
(3e,5r,7r,8r,10r,11r,12s,15r,16r,18z,25s)-11-ethyl-2,20,27-trihydroxy-10-methyl-21,26-diazapentacyclo[23.2.1.0⁵,¹⁶.0⁷,¹⁵.0⁸,¹²]octacosa-1,3,13,18,20,26-hexaen-28-one
8,8-dimethyl-2,9-dioxatetracyclo[25.3.1.0³,¹².0⁵,¹⁰]hentriaconta-1(30),3,5(10),6,11,27(31),28-heptaene-4,29-diol
(5s,7r,8r,10r,11r,12s,15s,16s,17e,25s)-11-ethyl-2,20,27-trihydroxy-10-methyl-21,26-diazapentacyclo[23.2.1.0⁵,¹⁶.0⁷,¹⁵.0⁸,¹²]octacosa-1,3,13,17,20,26-hexaen-28-one
(3ar,5ar,6s,9s,10ar)-9-ethoxy-1-isopropyl-3a,5a-dimethyl-6-{[(2s,3r,4s,5r)-3,4,5-trihydroxyoxan-2-yl]oxy}-2h,3h,4h,5h,6h,9h,10h,10ah-cyclohepta[e]indene-8-carbaldehyde
3a,7-dihydroxy-9a,11a-dimethyl-1-(2,3,6-trihydroxy-6-methylheptan-2-yl)-1h,2h,3h,5ah,6h,7h,9h,9bh,10h,11h-cyclopenta[a]phenanthrene-5,8-dione
22-oxo-20-hydroxyecdysone
{"Ingredient_id": "HBIN003750","Ingredient_name": "22-oxo-20-hydroxyecdysone","Alias": "NA","Ingredient_formula": "C27H42O7","Ingredient_Smile": "CC12CCC3C(=CC(=O)C4C3(CC(C(C4)O)O)C)C1(CCC2C(C)(C(=O)CCC(C)(C)O)O)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "16339","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
22-oxo-ajugasterone c
{"Ingredient_id": "HBIN003751","Ingredient_name": "22-oxo-ajugasterone c","Alias": "NA","Ingredient_formula": "C27H42O7","Ingredient_Smile": "Not Available","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "16280","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}